Recently, it was shown that knockdown of NFE2L3 reduced human colon cancer cell proliferation through an increase in the levels of DUX4, a protein that functions as a CDK1 inhibitor [22]. This evidence concerns the gene NFE2L3 and colonic neoplasm.